
Australian gaming company Aristocrat’s bid for gambling software company Playtech fell through on Wednesday, February 2, after the British company’s shareholders rejected the US$2.84 billion offer.
Australian gaming company Aristocrat had needed approval from 75% of Playtech shareholders at Wednesday’s meeting, but less than 55% of votes were cast in favor of the deal, reported Reuters.
Playtech’s share price rose 5% by 1348 GMT after the London-listed company stated it was considering other approaches, without elaborating.
Merger and acquisition business in the gaming and gambling sector has been brisk since the onset of the COVID-19 pandemic, with lockdowns boosting the popularity of online gaming.
Many of the takeover targets have been UK bookmakers, with suitors looking to acquire British expertise in the field. Ladbrokes-owner Entain has staved off two approaches from US rivals in the past year.
Playtech sparked interest from multiple players last year. It was approached by Hong Kong-based investor Gopher, its No.2 shareholder, and JKO Play consortium, led by former Formula One team boss Eddie Jordan.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Live Nation Under Criminal Antitrust Investigation Over Pandemic-Era Refund Policies
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas